# A Study of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia (MK0653-139)

> **NCT00783263** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 440 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Comparator: rosuvastatin 5 mg + ezetimibe 10 mg
- **DRUG:** Comparator: rosuvastatin 10 mg
- **DRUG:** Comparator: rosuvastatin 10 mg + ezetimibe 10 mg
- **DRUG:** Comparator: rosuvastatin 20 mg

## Key facts

- **NCT ID:** NCT00783263
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 440 (ACTUAL)
- **Last updated:** 2024-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00783263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00783263, "A Study of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia (MK0653-139)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00783263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*